During the recent years, considering specific preventive role of astatines in patients at high risk of acute cardiovascular attacks, astatines are widely consumed. Considering respective statistics in 2006, 76% of unexpected sale has been allocated to Astatines for 26.- Billion Dollars.
As reported by the reporter for site of Borderless Physicians, various clinical studies recently contracted all over the world on astatines have shown advantages of controllers of 3 hydroxy 3 methylglutaryl coenzyme a hmg coa retractase inhibitors with astatines have been propounded for primary and secondary prevention of cardiovascular diseases. According to the results of studies, it has been found that in addition to its simple effect on decrease of blood cholesterol, astatine enjoys other remarkable advantages and these medical compounds may also be used for treatment and prevention of non-cardiac disorders such as cancers, infections, Alzheimer’s disease, chronic occlusive diseases, chronic occlusive pulmonary disorders and other functional pulmonary complications and polycystic ovary syndrome accordingly. It should be mentioned that role of astatines in treatment or prevention of the aforesaid diseases has not been proved yet.
Astatines prevent cellular multiplication and enjoy anti-inflammatory and immunity suppressing effect. Thus, we may use this group of medicines for recovery of specific diseases.